Published on 23 Jan 2022 on MSN News
CytomX (CTMX) Gets FDA Nod to Begin Study in Solid Tumors
CytomX Therapeutics, Inc. CTMX announced that the FDA has approved its investigational new drug...
NASDAQ.CARA price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free